Related Experiment Video
Updated: Jun 28, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic
Daniel Huff1, Neil M Ampel2, Janis E Blair3
1Department of Medicine, Mayo Clinic in Arizona, Phoenix, Arizona, USA.
Abstract:
At a single medical center, we identified 60 cases of coccidioidomycosis that were coincident with COVID-19 infection. Among these, seven patients developed new or clinically progressive coccidioidomycosis. Receipt of dexamethasone for COVID-19 infection was the only significant risk factor for the progression or development of clinically active coccidioidomycosis in this cohort. All patients survived and none developed disseminated coccidioidomycosis.
Related Concept Videos
Fungal Phylum Microsporidia
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease
Cryptococcal Meningitis
Toxoplasmosis
Candidiasis

